MedPath

海南倍特药业有限公司

Ownership
-
Established
2004-07-29
Employees
-
Market Cap
-
Website
www.levtec.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

102

NMPA:102

Drug Approvals

Polymyxin B Sulfate for Injection

Product Name
注射用硫酸多粘菌素B
Approval Number
国药准字H20254404
Approval Date
Jun 3, 2025
NMPA

Potassium Aspartate Injection

Product Name
门冬氨酸钾注射液
Approval Number
国药准字H20254312
Approval Date
May 27, 2025
NMPA

Vancomycin Hydrochloride for Injection

Product Name
注射用盐酸万古霉素
Approval Number
国药准字H20253781
Approval Date
Apr 1, 2025
NMPA

Esmolol Hydrochloride Injection

Product Name
盐酸艾司洛尔注射液
Approval Number
国药准字H20253719
Approval Date
Mar 25, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258017
Approval Date
Feb 19, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258018
Approval Date
Feb 19, 2025
NMPA

Phenylephrine Hydrochloride Injection

Product Name
盐酸去氧肾上腺素注射液
Approval Number
国药准字H20249841
Approval Date
Dec 25, 2024
NMPA

Phenylephrine Hydrochloride Injection

Product Name
盐酸去氧肾上腺素注射液
Approval Number
国药准字H20249840
Approval Date
Dec 25, 2024
NMPA

Ademetionine Butanedisulfonate for Injection

Product Name
注射用丁二磺酸腺苷蛋氨酸
Approval Number
国药准字H20249623
Approval Date
Dec 1, 2024
NMPA

Roxatidine Acetate Hydrochloride for Injection

Product Name
注射用盐酸罗沙替丁醋酸酯
Approval Number
国药准字H20249526
Approval Date
Dec 1, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.